Fig. 2From: Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT18F-DOPA PET/CT MIP (a) and 68Ga-HA-DOTATATE PET/CT MIP (b) performed 22Â days apart. While some metastases were DOTATATE-avid, the 18F-DOPA scan revealed many more sites of discordant non-DOTATATE-avid diseaseBack to article page